Jun 30, 2014

Gilead Sciences Q2 2014 Earnings Report

Total Revenue
$6.53B
Previous year: $2.66B
+145.7%
EPS
$2.36
Previous year: $0.5
+372.0%
Gross Profit
$5.61B
Previous year: $2.08B
+169.4%
Cash and Equivalents
$8.73B
Previous year: $2.2B
+296.5%
Free Cash Flow
$3.93B
Total Assets
$31.2B
Previous year: $22.6B
+37.9%

Gilead Sciences

Gilead Sciences